Search results
Results from the WOW.Com Content Network
24,832 (March 2023) Website. www .drreddys .com. Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2] Dr.
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, the most populous combined statistical area in the United States and one of the most populous megacities in the world.
Jeeri Reddy an American biologist who became an entrepreneur, developing new generation preventive and therapeutic vaccines. He has been an active leader in the field of the biopharmaceutical industry, commercializing diagnostics and vaccines through JN-International Medical Corporation. He is the scientific director and president of the ...
Dr. Reddy's Laboratories (NYS: RDY) reported earnings on May 11. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended March 31 (Q4), Dr. Reddy's Laboratories beat ...
Dr. Reddy's Labs quotes IMS Health in noting the branded drug had domestic sales of approximately $300.5 million for the trailing 12-month period ending in April.
The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization.
Kallam Satish Reddy (son) G. V. Prasad (son-in-law) Kallam Anji Reddy (10 August 1941 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group ...
Kallam Satish Reddy is an Indian business executive and current Chairman of Dr. Reddy's Laboratories. [2] [3] Reddy joined Dr. Reddy's Laboratories in 1993 as executive director. Elevated to the role of Managing Director in 1997, he led the company's transition from a manufacturer of active pharmaceutical ingredients to one with a diverse ...